The Xolair Pregnancy Registry (EXPECT): Perinatal Outcomes among Pregnant Women with Asthma Treated with Omalizumab (Xolair) Compared against Those of a Cohort of Pregnant Women with Moderate-to-Severe Asthma

被引：0

作者：

Namazy, J. ^{[1
]}

Blais, L. ^{[2
]}

Andrews, E. B. ^{[3
]}

Scheuerle, A. E. ^{[4
]}

Cabana, M. D. ^{[5
]}

Thorp, J. M. ^{[6
]}

Veith, J. H. ^{[7
]}

Umetsu, D. ^{[7
]}

Sun, D. ^{[7
]}

Kaufman, D. G. ^{[7
]}

Convington, D. L. ^{[8
]}

Mukhopadhyay, S. ^{[9
]}

Fogel, R. ^{[9
]}

Lopez-Leon, S. ^{[9
]}

Spain, V ^{[7
]}

机构：

[1] Scripps Clin, San Diego, CA USA

[2] Univ Montreal, Montreal, PQ, Canada

[3] RTI Hlth Solut, Res Triangle Pk, NC USA

[4] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA

[5] Univ Calif San Francisco, San Francisco, CA 94143 USA

[6] Univ N Carolina, Chapel Hill, NC 27515 USA

[7] Genentech Inc, San Francisco, CA 94080 USA

[8] Evidera, Morristown, NC USA

[9] Novartis Inc, E Hanover, NJ USA

来源：

BIRTH DEFECTS RESEARCH | 2019年 / 111卷 / 09期

关键词：

D O I：

暂无

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：481 / 481

页数：1

共 15 条

[1] The Xolair Pregnancy Registry (EXPECT): Perinatal outcomes among pregnant women with asthma treated with omalizumab (Xolair) compared against those of a cohort of pregnant women with moderate-to-severe asthma
Namazy, Jennifer A.
Blais, Lucie
Andrews, Elizabeth B.
Scheuerle, Angela E.
Cabana, Michael D.
Thorp, John M.
Veith, Joachim H.
Umetsu, Dale T.
Sun, Diana
Kaufman, Derrick G.
Covington, Deborah L.
Mukhopadhyay, Santanu
Fogel, Robert B.
Lopez-Leon, Sandra
Spain, Vic
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB103 - AB103
[2] The Xolair Pregnancy Registry (EXPECT): An Observational Study of the Safety of Omalizumab during Pregnancy in Women with Asthma
Namazy, Jennifer
Miller, Mary K.
Wang, Vivian
Gershman, Ari
Andrews, Elizabeth
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S55 - S56
[3] The Xolair Pregnancy Registry (EXPECT): Design of an Observational Study of Safety of (Omalizumab) During Pregnancy in Women With Asthma
Namazy, J.
Miller, M. K.
Wang, V
Gershman, A.
Andrews, E.
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2011, 91 (05) : 387 - 387
[4] The Xolair Pregnancy Registry (Expect): Design Of An Observational Study Of Safety Of (Omalizumab) During Pregnancy In Women With Asthma
Namazy, J. A.
Miller, M. K.
Wang, V.
Gershman, A.
Andrews, E.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
[5] Omalizumab (Xolair®) increases the number of asthma controlled days in moderate-to-severe asthma patients compared to placebo
Chung, F
Fox, H
Thirlwell, J
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) : S112 - S112
[6] Omalizumab (Xolair®) increased the time to first exacerbation in patients with moderate-to-severe asthma compared with placebo
O'Brien, JA
Fox, H
Thirlwell, J
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) : S107 - S107
[7] Pregnancy and infant outcomes among pregnant women with Chronic Spontaneous Urticaria (CSU) treated with omalizumab: a descriptive analysis from the EXPECT pregnancy registry
Namazy, Jennifer
Scheuerle, Angela
Spain, Vic
Janampally, Pranathi
Ahmed, Ayesha
Gupta, Sachin
Holweg, Cecile
Mumneh, Nayla
Radojicic, Cristine
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB145 - AB145
[8] Omalizumab in pregnant women treated due to severe asthma: two case reports of good outcomes of pregnancies
Kuprys-Lipinska, Izabela
Tworek, Damian
Kuna, Piotr
POSTEPY DERMATOLOGII I ALERGOLOGII, 2014, 31 (02): : 104 - 107
[9] Maternal and fetal perinatal outcomes among pregnant Women hospitalized with uncontrolled asthma in Assiut university hospitals
Mohamed-Hussein, Aliae
Mostafa, Olfat
Talaat, Raefat
Ismail, Eman
EUROPEAN RESPIRATORY JOURNAL, 2013, 42
[10] Maternal and fetal perinatal outcomes among hospitalised pregnant women with uncontrolled asthma in Assiut university hospitals
Mohamed-Hussein, A.
Elshinawy, O.
Elsokkary, R.
Tohami, E.
Rady, Abdel S.
ALLERGY, 2012, 67 : 457 - 457

← 1 2 →